Chinese Japanese Germany Korea
ChemicalBook >> CAS DataBase List >>butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate

butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate

butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Structure
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate structure
CAS No.
2227199-31-5
Chemical Name:
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
Synonyms
Tofatinib Impurity 12;Tofacitib related impurities 40;N-Butyl 3-Oxopropanoate Tofacitinib;Butyl 3-[4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanoate;Butyl 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate;1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, butyl ester, (3R,4R)-;3-(3R,4R)-3-(6,7-dihydro-5H-pyrrolo[2,3d]pyrimidin-4-yl x(methyl)amino)4-methylpiperidin-1-yl)-3-oxopropionic acid]butyl ester;Butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate (Tofacitinib Impurity）
CBNumber:
CB23956193
Molecular Formula:
C20H29N5O3
Molecular Weight:
387.47596
MDL Number:
MFCD31705068
MOL File:
2227199-31-5.mol
Last updated:2024-05-20 18:13:44
Request For Quotation

butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Properties

Density 1?+-.0.06 g/cm3(Predicted)
pka 13.31±0.50(Predicted)
FDA UNII EXA92262Y4

butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Chemical Properties,Uses,Production

Uses

N-Butyl 3-oxopropanoate Tofacitinib is an impurity of Tofacitinib(T528000) which is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.

butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Preparation Products And Raw materials

Raw materials

Preparation Products

butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Suppliers

Global( 24)Suppliers
Supplier Tel Email Country ProdList Advantage
ANHUI WITOP BIOTECH CO., LTD 		+8615255079626 eric@witopchemical.com China 23556 58
China National Standard Pharmaceutical Corporation Limited 		+8615391658522 overseasales@yongstandards.com China 11927 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 		+8618627948422 sale@hdimpurity.com China 3389 58
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656 greensnown@163.com China 9911 50
Hubei Yangxin Medical Technology Co., Ltd. 15374522761 3003392093@qq.com China 8295 55
TOSUN PHARM 020-61855200 13326451905 260366801@qq.com China 7718 58
Guangzhou Dreampharm Biotechnology Co., Ltd. 020-36607679 17825480238 3008233717@qq.com China 9875 12
Tianjin shijia biomedical technology co., LTD 15022261580 tjshj1212@163.com China 2442 58
Shenzhen ruikai de biotechnology co., ltd. 0755-61348847 17820674378 2682116078@qq.com China 7844 58
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd 15850510341 shiqingran@wzxchem.com China 3639 58
Supplier Advantage
ANHUI WITOP BIOTECH CO., LTD 		58
China National Standard Pharmaceutical Corporation Limited 		58
ShenZhen H&D Pharmaceutical Technology Co., LTD 		58
Shanghai Kewel Chemical Co., Ltd. 50
Hubei Yangxin Medical Technology Co., Ltd. 55
TOSUN PHARM 58
Guangzhou Dreampharm Biotechnology Co., Ltd. 12
Tianjin shijia biomedical technology co., LTD 58
Shenzhen ruikai de biotechnology co., ltd. 58
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd 58

View Lastest Price from butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Tofacitinib Impurity 99 pictures 2024-08-28 Tofacitinib Impurity 99
2227199-31-5
 US $0.00-0.00 / mg 10mg 0.98 10g ShenZhen H&D Pharmaceutical Technology Co., LTD

2227199-31-5(butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate)Related Search:

(3R,4R)-N,1,4-trimethyl-N-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-3-amine N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity Tofacitinib Impurity 36 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Tofacitinib Impurity 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine 1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE
Tofacitinib Related Compound Tofacitinib Impurity 45 Tofacitinib Impurity 2

1of4

Tofacitib related impurities 40 Butyl 3-[4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanoate N-Butyl 3-Oxopropanoate Tofacitinib Tofatinib Impurity 12 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, butyl ester, (3R,4R)- Butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate (Tofacitinib Impurity） Butyl 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate 3-(3R,4R)-3-(6,7-dihydro-5H-pyrrolo[2,3d]pyrimidin-4-yl x(methyl)amino)4-methylpiperidin-1-yl)-3-oxopropionic acid]butyl ester 2227199-31-5